My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 247

    1.

    Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure.

    Nichol G, Kaul P, Huszti E, Bridges JF.

    Ann Intern Med. 2004 Sep 7;141(5):343-51. Epub 2004 Aug 16.PMID: 15353425 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

    Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

    Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.PMID: 17999842 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.

    Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG.

    Eur Heart J. 2007 Jan;28(1):42-51. Epub 2006 Nov 16.PMID: 17110403 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Summaries for patients. The cost-effectiveness of cardiac resynchronization therapy for heart failure.

    [No authors listed]

    Ann Intern Med. 2004 Sep 7;141(5):I29. Epub 2004 Aug 16. No abstract available. PMID: 15353442 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.

    Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR.

    J Am Coll Cardiol. 2005 Dec 20;46(12):2311-21.PMID: 16360064 [PubMed - indexed for MEDLINE]Related articles

    6.

    A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

    Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

    Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.PMID: 16904046 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Cardiac resynchronization therapy (CRT) in heart failure--a model to assess the economic value of this new medical technology.

    Banz K; Eucomed CRT Steering Committee.

    Value Health. 2005 Mar-Apr;8(2):128-39.PMID: 15804321 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cost-effectiveness of cardiac resynchronization therapy in combination with an implantable cardioverter defibrillator (CRT-D) for the treatment of chronic heart failure from a German health care system perspective.

    Aidelsburger P, Grabein K, Klauss V, Wasem J.

    Clin Res Cardiol. 2008 Feb;97(2):89-97. Epub 2007 Oct 25.PMID: 17955159 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cost-effectiveness of implantable cardioverter-defibrillators.

    Sanders GD, Hlatky MA, Owens DK.

    N Engl J Med. 2005 Oct 6;353(14):1471-80.PMID: 16207849 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

    Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

    Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.PMID: 16545208 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Cost effectiveness of defibrillation by targeted responders in public settings.

    Nichol G, Valenzuela T, Roe D, Clark L, Huszti E, Wells GA.

    Circulation. 2003 Aug 12;108(6):697-703. Epub 2003 Aug 4.PMID: 12900345 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone.

    Schleinitz MD, Heidenreich PA.

    Ann Intern Med. 2005 Feb 15;142(4):251-9.PMID: 15710958 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Modelling the economic and health consequences of cardiac resynchronization therapy in the UK.

    Caro JJ, Guo S, Ward A, Chalil S, Malik F, Leyva F.

    Curr Med Res Opin. 2006 Jun;22(6):1171-9.PMID: 16846550 [PubMed - indexed for MEDLINE]Related articles

    14.

    Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.

    Sanders GD, Hlatky MA, Every NR, McDonald KM, Heidenreich PA, Parsons LS, Owens DK.

    Ann Intern Med. 2001 Nov 20;135(10):870-83.PMID: 11712877 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

    Shepherd J, Jones J, Takeda A, Davidson P, Price A.

    Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure.

    Chen L, Hay JW.

    Cardiovasc Drugs Ther. 2004 Mar;18(2):161-70.PMID: 15162078 [PubMed - indexed for MEDLINE]Related articles

    17.

    Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.

    Venditti LN, Venditti CP, Berry GT, Kaplan PB, Kaye EM, Glick H, Stanley CA.

    Pediatrics. 2003 Nov;112(5):1005-15.PMID: 14595039 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial.

    Calvert MJ, Freemantle N, Yao G, Cleland JG, Billingham L, Daubert JC, Bryan S; CARE-HF investigators.

    Eur Heart J. 2005 Dec;26(24):2681-8. Epub 2005 Nov 11.PMID: 16284203 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

    Hornberger J, Robertus K.

    Ann Intern Med. 2006 Sep 5;145(5):317-25.PMID: 16954357 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

    Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

    Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.PMID: 17999840 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity